American Research & Management Company’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $2.52M | Buy |
30,520
+1,594
| +6% | +$132K | 0.7% | 42 |
|
|
2022
Q2 | $2.75M | Buy |
28,926
+1,220
| +4% | +$116K | 0.71% | 42 |
|
|
2022
Q1 | $3.26M | Buy |
27,706
+74
| +0.3% | +$8.71K | 0.72% | 43 |
|
|
2021
Q4 | $3.58M | Sell |
27,632
-10
| -0% | -$1.3K | 0.77% | 41 |
|
|
2021
Q3 | $3.13M | Sell |
27,642
-65
| -0.2% | -$7.36K | 0.72% | 41 |
|
|
2021
Q2 | $2.87M | Buy |
27,707
+1,145
| +4% | +$119K | 0.65% | 46 |
|
|
2021
Q1 | $2.22M | Buy |
26,562
+117
| +0.4% | +$9.79K | 0.54% | 48 |
|
|
2020
Q4 | $2.41M | Buy |
26,445
+363
| +1% | +$33.1K | 0.63% | 45 |
|
|
2020
Q3 | $2.08M | Hold |
26,082
| – | – | 0.61% | 44 |
|
|
2020
Q2 | $1.8M | Buy |
+26,082
| New | +$1.8M | 0.55% | 49 |
|
|
2018
Q3 | – | Sell |
-23,580
| Closed | -$1.14M | – | 344 |
|
|
2018
Q2 | $1.14M | Buy |
+23,580
| New | +$1.14M | 0.4% | 56 |
|
|
2017
Q4 | – | Sell |
-22,230
| Closed | -$810K | – | 362 |
|
|
2017
Q3 | $810K | Buy |
22,230
+300
| +1% | +$10.9K | 0.26% | 71 |
|
|
2017
Q2 | $864K | Buy |
21,930
+900
| +4% | +$35.5K | 0.28% | 69 |
|
|
2017
Q1 | $659K | Buy |
21,030
+1,305
| +7% | +$40.9K | 0.23% | 67 |
|
|
2016
Q4 | $616K | Buy |
+19,725
| New | +$616K | 0.21% | 74 |
|
|
2016
Q3 | – | Sell |
-3,900
| Closed | -$130K | – | 98 |
|
|
2016
Q2 | $130K | Buy |
+3,900
| New | +$130K | 0.05% | 114 |
|